These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25363430)

  • 1. Contemporary health care economics: an overview.
    McLaughlin N; Ong MK; Tabbush V; Hagigi F; Martin NA
    Neurosurg Focus; 2014 Nov; 37(5):E2. PubMed ID: 25363430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluations in fracture research an introduction with examples of foot fractures.
    van den Boom N; van den Hurk AA; Kalmet P; Poeze M; Evers S
    Injury; 2022 Mar; 53(3):895-903. PubMed ID: 35034777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis in minimally invasive spine surgery.
    Al-Khouja LT; Baron EM; Johnson JP; Kim TT; Drazin D
    Neurosurg Focus; 2014 Jun; 36(6):E4. PubMed ID: 24881636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of reporting quality of economic evaluations in plastic surgery based on the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
    Miroshnychenko A; Uhlman K; Malone J; Waltho D; Thoma A
    J Plast Reconstr Aesthet Surg; 2021 Oct; 74(10):2458-2466. PubMed ID: 34217645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Economic evaluation of targeted cancer therapy].
    Ikeda S
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):967-70. PubMed ID: 23986036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of the COVID-19 pandemic: economic evaluation of government mitigation and suppression policies, health system innovations, and models of care.
    Antioch KM
    Z Gesundh Wiss; 2023 May; ():1-16. PubMed ID: 37361278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropharmacoeconomics].
    Chiu HC
    Acta Neurol Taiwan; 2004 Jun; 13(2):87-96. PubMed ID: 15478681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on health economics regarding the screening of gastric cancer in Zhuanghe high risk area].
    Pan S; He QC; Zhou BS; Yuan Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Oct; 26(10):757-60. PubMed ID: 16536299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parameter of evidence-based medicine in health care economics].
    Wasem J; Siebert U
    Z Arztl Fortbild Qualitatssich; 1999 Aug; 93(6):427-36. PubMed ID: 10519192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assessment of published health economic analyses from South America.
    Machado M; Iskedjian M; Einarson TR
    Ann Pharmacother; 2006 May; 40(5):943-9. PubMed ID: 16670369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic studies: an introduction to cost-benefit, cost-effectiveness, and cost-utility analyses.
    Angevine PD; Berven S
    Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S9-15. PubMed ID: 25299265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
    Laupacis A; Feeny D; Detsky AS; Tugwell PX
    CMAJ; 1992 Feb; 146(4):473-81. PubMed ID: 1306034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of public health interventions examined by NICE from 2011 to 2016.
    Owen L; Pennington B; Fischer A; Jeong K
    J Public Health (Oxf); 2018 Sep; 40(3):557-566. PubMed ID: 28977629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic reviews of economic evaluations: utility or futility?
    Anderson R
    Health Econ; 2010 Mar; 19(3):350-64. PubMed ID: 19378354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness analysis: a review.
    Rutigliano MJ
    Neurosurgery; 1995 Sep; 37(3):436-43; discussion 443-4. PubMed ID: 7501108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.
    Hawton A; Shearer J; Goodwin E; Green C
    Appl Health Econ Health Policy; 2013 Aug; 11(4):331-41. PubMed ID: 23637055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
    Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
    Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness as an outcome in randomized clinical trials.
    Hlatky MA; Owens DK; Sanders GD
    Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.